Dr. Sameer Farouk Sait
Claim this profileMemorial Sloan Kettering Cancer Center
Area of expertise
Brain Tumor
Sameer Farouk Sait has run 5 trials for Brain Tumor. Some of their research focus areas include:
Brain Cancer
Sameer Farouk Sait has run 4 trials for Brain Cancer. Some of their research focus areas include:
Affiliated Hospitals
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
Clinical Trials Sameer Farouk Sait is currently running
Selumetinib vs. Chemotherapy
for Brain Cancer
This trial is comparing a new drug, selumetinib, with standard chemotherapy to treat patients with a specific type of brain tumor. The patients do not have a certain genetic mutation and are not affected by a genetic disorder. Selumetinib works by blocking enzymes needed for tumor growth, while the standard drugs kill or stop tumor cells from dividing.
Recruiting
2 awards
Phase 3
Chemotherapy + Radiation Therapy
for Brain Cancer
This phase II trial studies the best approach to combine chemotherapy and radiation therapy (RT) based on the patient's response to induction chemotherapy in patients with non-germinomatous germ cell tumors (NGGCT) that have not spread to other parts of the brain or body (localized). This study has 2 goals: 1) optimizing radiation for patients who respond well to induction chemotherapy to diminish spinal cord relapses, 2) utilizing higher dose chemotherapy followed by conventional RT in patients who did not respond to induction chemotherapy. Chemotherapy drugs, such as carboplatin, etoposide, ifosfamide, and thiotepa, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Radiation therapy uses high energy x-rays or high-energy protons to kill tumor cells and shrink tumors. Studies have shown that patients with newly-diagnosed localized NGGCT, whose disease responds well to chemotherapy before receiving radiation therapy, are more likely to be free of the disease for a longer time than are patients for whom the chemotherapy does not efficiently eliminate or reduce the size of the tumor. The purpose of this study is to see how well the tumors respond to induction chemotherapy to decide what treatment to give next. Some patients will be given RT to the spine and a portion of the brain. Others will be given high dose chemotherapy and a stem cell transplant before RT to the whole brain and spine. Giving treatment based on the response to induction chemotherapy may lower the side effects of radiation in some patients and adjust the therapy to a more efficient one for other patients with localized NGGCT.
Recruiting
1 award
Phase 2
More about Sameer Farouk Sait
Clinical Trial Related
6 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Sameer Farouk Sait has experience with
- Radiation Therapy
- Selumetinib
- Avutometinib
- Neratinib
- Vinblastine Sulfate
- Selumetinib Sulfate
Breakdown of trials Sameer Farouk Sait has run
Brain Tumor
Brain Cancer
Low Grade Glioma
Central Nervous System Neoplasm
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Sameer Farouk Sait specialize in?
Sameer Farouk Sait focuses on Brain Tumor and Brain Cancer. In particular, much of their work with Brain Tumor has involved NF1 positive patients, or patients who are BRAF positive.
Is Sameer Farouk Sait currently recruiting for clinical trials?
Yes, Sameer Farouk Sait is currently recruiting for 2 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Sameer Farouk Sait has studied deeply?
Yes, Sameer Farouk Sait has studied treatments such as Radiation Therapy, Selumetinib, Avutometinib.
What is the best way to schedule an appointment with Sameer Farouk Sait?
Apply for one of the trials that Sameer Farouk Sait is conducting.
What is the office address of Sameer Farouk Sait?
The office of Sameer Farouk Sait is located at: Memorial Sloan Kettering Cancer Center, New York, New York 10065 United States. This is the address for their practice at the Memorial Sloan Kettering Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.